Research map: Combining circulating tumor cells and tumor-derived extracellular vesicles for prognosis stratification in patients with metastatic breast cancer

Back to the article

Papers in this map

  1. Circulating Tumor Cells, Disease Progression, and Survival in Metastatic Breast Cancer · Massimo Cristofanilli · 2004 · 4641 citations · Cited by this paper
  2. 61eP Radiotherapy combined with PARP inhibition in BRCA-mutated breast cancer: A systematic review of clinical outcomes and toxicity · 2026 · Related
  3. Minimal information for studies of extracellular vesicles (MISEV2023): From basic to advanced approaches · Joshua A Welsh · 2024 · 4417 citations · Cited by this paper
  4. Nectin-4 and Trop-2 expression in collecting duct carcinoma: new promising therapeutic targets · 2026 · Related
  5. Tumor Cells Circulate in the Peripheral Blood of All Major Carcinomas but not in Healthy Subjects or Patients With Nonmalignant Diseases · W. Jeffrey Allard · 2004 · 2548 citations · Cited by this paper
  6. 149P Adjuvant radiotherapy outcomes for early stage (stage 1c-2) clear cell ovarian carcinoma in Edinburgh cancer centre · 2026 · Related
  7. Reporting Recommendations for Tumor Marker Prognostic Studies (REMARK) · Lisa M. McShane · 2005 · 2136 citations · Cited by this paper
  8. 213P Glandular tissue–based versus anatomical landmark–based CTV delineation in postoperative breast cancer radiotherapy: A dosimetric comparison · 2026 · Related
  9. Trastuzumab Deruxtecan after Endocrine Therapy in Metastatic Breast Cancer · Aditya Bardia · 2024 · 465 citations · Cited by this paper
  10. 194eP Ovarian cancer during pregnancy: Maternal and fetal outcomes from a systematic review and meta-analysis · 2026 · Related
  11. Breast Tumor Heterogeneity: Source of Fitness, Hurdle for Therapy · Shany Koren · 2015 · 294 citations · Cited by this paper
  12. 67RO Single-cell and TCR profiling reveals pre-existing cytotoxic CD8 T cell clonal expansion and peripheral–tumor dissociation associated with response to PD-1-based therapy in hepatocellular carcinoma · 2026 · Related
  13. The clinical use of circulating tumor cells (CTCs) enumeration for staging of metastatic breast cancer (MBC): International expert consensus paper · Massimo Cristofanilli · 2018 · 277 citations · Cited by this paper
  14. 219P Clinical profile and treatment outcomes of lymphoma patients: A retrospective cohort study · 2026 · Related
  15. Efficacy of Circulating Tumor Cell Count–Driven vs Clinician-Driven First-line Therapy Choice in Hormone Receptor–Positive, ERBB2-Negative Metastatic Breast Cancer · François‐Clément Bidard · 2020 · 185 citations · Cited by this paper
  16. A phase Ib/II, open-label, multicenter, randomized umbrella study evaluating the combination of atezolizumab with sacituzumab govitecan in patients with locally advanced or metastatic urothelial carcinoma and previously treated with a platinum-based treatment regimen (MORPHEUS-Urothelial Carcinoma) · 2026 · Related
  17. Tumour-derived extracellular vesicles in blood of metastatic cancer patients associate with overall survival · Afroditi Nanou · 2020 · 85 citations · Cited by this paper
  18. 152P Efficacy and safety of relacorilant + nab-paclitaxel in patients aged ≥65 years with platinum-resistant ovarian cancer (PROC) in the phase III ROSELLA study (GOG-3073, ENGOT-ov72, APGOT-Ov10) · 2026 · Related
  19. Circulating tumor cells, tumor-derived extracellular vesicles and plasma cytokeratins in castration-resistant prostate cancer patients · Afroditi Nanou · 2018 · 75 citations · Cited by this paper
  20. 232eP GLP-1 receptor agonists and risk of incident endometrial, colorectal, and hepatocellular cancer: A systematic review and meta-analysis · 2026 · Related
  21. Tumor-derived extracellular vesicles in breast cancer: From bench to bedside · Hongxia Wang · 2019 · 72 citations · Cited by this paper
  22. HER2 expression on tumor-derived extracellular vesicles and circulating tumor cells in metastatic breast cancer · Afroditi Nanou · 2020 · 58 citations · Cited by this paper
  23. Automated enumeration and phenotypic characterization of CTCs and tdEVs in patients with metastatic castration resistant prostate cancer · Steffi Oeyen · 2020 · 52 citations · Cited by this paper
  24. Overall Survival With Circulating Tumor Cell Count–Driven Choice of Therapy in Advanced Breast Cancer: A Randomized Trial · François‐Clément Bidard · 2023 · 50 citations · Cited by this paper
  25. Quantifying HER-2 expression on circulating tumor cells by ACCEPT · Leonie L. Zeune · 2017 · 48 citations · Cited by this paper
  26. Circulating tumor cells in breast cancer: clinical validity and utility · Thibault Thomas-Bonafos · 2024 · 45 citations · Cited by this paper
  27. Circulating tumor cells et al.: towards a comprehensive liquid biopsy approach in breast cancer · Eleonora Nicolò · 2024 · 21 citations · Cited by this paper
  28. The Distribution of Circulating Tumor Cells Is Different in Metastatic Lobular Compared to Ductal Carcinoma of the Breast—Long-Term Prognostic Significance · Ulrik Narbe · 2020 · 17 citations · Cited by this paper
  29. Characterizing Circulating Tumor Cells and Tumor-Derived Extracellular Vesicles in Metastatic Castration-Naive and Castration-Resistant Prostate Cancer Patients · Khrystany T. Isebia · 2022 · 16 citations · Cited by this paper
  30. Large tumour-derived extracellular vesicles as prognostic indicators of metastatic cancer patient survival · Deborah C. I. Goberdhan · 2022 · 9 citations · Cited by this paper
  31. Blood tumor load: combining biomarkers to increase the proportion of informative patients · Eshwari Dathathri · 2025 · 6 citations · Cited by this paper
  32. Blood Extracellular Vesicles Beyond Circulating Tumour Cells: A Valuable Risk Stratification Biomarker in High-Risk Non-Muscle-Invasive Bladder Cancer Patients · Valentina Magri · 2024 · 4 citations · Cited by this paper
  33. Circulating Tumor Cell Dynamics after CDK4/6 Inhibitor for Hormone Receptor–Positive Metastatic Breast Cancer: A Biomarker Analysis from the PACE Phase II Study · Lorenzo Gerratana · 2025 · 4 citations · Cited by this paper
  34. Prognostic Significance and Predictive Value of Circulating Tumor Cells in Invasive Lobular Breast Carcinoma—An Exploratory Analysis of the STIC CTC Trial · José Luís Sandoval · 2025 · 4 citations · Cited by this paper
  35. Expanding the use of T-DXd in metastatic HR-positive breast cancer: where are we now? · Joshua Z. Drago · 2024 · 2 citations · Cited by this paper
  36. Untitled · Cited by this paper

Source: OpenAlex (CC0)